All branded medicines (except branded medicines on therapeutic tender) were tendered on a pan London basis for a 2 year contract which commenced 1st Jul 14.
Benefits of the contract
The savings are reported on lines where there was a reduction in price compared to the previous consortia contracts. The savings are calculated from the Pharmex database using the NHS CMU's Benefits Tracking Tool. The Pharmex database is populated from trust pharmacy system purchase data. Where a trust sells products onto other trusts the saving for these products will be included in the sellers data.
New baselines for each trust will be calculated from the previous average monthly saving between 30th Jun 2013.